2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- PMID: 24222016
- DOI: 10.1161/01.cir.0000437738.63853.7a
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Erratum in
- Circulation. 2014 Jun 24;129(25 Suppl 2):S46-8
-
Correction.Circulation. 2015 Dec 22;132(25):e396. doi: 10.1161/CIR.0000000000000346. Epub 2015 Dec 14. Circulation. 2015. PMID: 26667225 No abstract available.
Keywords: AHA Scientific Statements; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention.
Comment in
-
2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.Cardiovasc Drugs Ther. 2014 Jun;28(3):203-4. doi: 10.1007/s10557-014-6513-1. Cardiovasc Drugs Ther. 2014. PMID: 24610170 No abstract available.
-
Treatment of hypercholesterolemia - a revolution.Climacteric. 2014 Apr;17(2):205-6. Climacteric. 2014. PMID: 24765643 No abstract available.
-
Interpretation and Use of Another Statin Guideline.JAMA. 2016 Nov 15;316(19):1977-1979. doi: 10.1001/jama.2016.15087. JAMA. 2016. PMID: 27838703 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical